Aerial view of the Cancún coastline

Immunocine Summit 2026

A Weekend at the Frontier
of Cancer Immunotherapy

You've been personally invited to join us in Cancún for three days of science, connection, and a look inside what we're building at Immunocine Cancer Center.

August 6–9, 2026 Cancún, México Arrivals on August 6 • Programming begins August 7

By invitation only; Flights, hotel, and airport ground transfers complimentary.

01 — About

This isn't a conference. It's a conversation.

The Immunocine Summit is a small, curated gathering of the people shaping the future of cancer — oncologists and specialists who are on the front lines of cancer care every day.

We're not here to pitch you. We're here to show you what we've built, share what the data looks like, and spend some real time together in a place worth the trip.

Immunocine team members in conversation

02 — The Weekend

A Summit designed with intention.

From arrival to departure, every hour is intentional. On Friday, join us in the JW Marriott Conference Center - Uxmal I & II at 4:00pm to begin our time together.

FRIDAY, AUGUST 7

Meet the team, learn the science.

4:00pm — JW Marriott Conference Center - Uxmal I & II

Welcome Presentation
Matthew Halpert, PhD — Immunocine Founder & CEO
An overview of the science, the protocol, and where we're headed.

5:15pm

Partner Presentation
Jay Hartenbach — COO, Diakonos
A look at the broader ecosystem of double-loaded dendritic cells.

5:50pm

Open Q&A Panel
Sit down with Matt Halpert, Jay Hartenbach, Dan Rubin, Stephen Noga, and Janet Maendel. No agenda — ask what you actually want to know.

6:30pm

Welcome Dinner
The rest of the evening is yours. Good food. Real conversation.

SATURDAY, AUGUST 8

Go behind the scenes.

9:30 am

Group 1 Pickup — Meet Mary in the JW Marriott Lobby

Morning Session

Immunocine Facility & Lab Tour
You'll move through the facility in small groups — keeping things personal and unhurried. See exactly how the protocol works from cell collection through infusion.

Presentations — Clinical Deep Dive

  • Patient Care: How we work with patients through treatment
  • Referring a Patient: The full lifecycle from first call to follow-up
Amerimed Hospital Tour
A walkthrough of our hospital partnership.
Q&A Sessions
Dedicated time after each presentation to ask anything.

5:00pm - 7:00pm — JW Marriott - Seaside Garden

Happy Hour
Hors d'oeuvres & live music — location TBD.

03 — The Treatment

Teaching the immune system to fight back.

What you'll see and learn over the weekend.

Immunocine's approach is built on a single insight: the immune system already knows how to fight cancer — it just needs better intelligence.

Our double-loaded Dendritic Cell therapy trains the patient's own immune cells using their specific tumor antigens. No broad-spectrum attack. No off-target damage. A targeted response, built from the patient's own biology.

Over the weekend, you'll get a full walkthrough of the protocol — from intake and cell processing to infusion and patient monitoring. You'll see the facility. You'll meet the team. And you'll leave with a clear picture of which patients are the right candidates.

100+

patients treated with the double-loaded Dendritic Cell protocol.

15+

cancer types — bladder, breast, colorectal, kidney, melanoma, ovarian, pancreatic, prostate, and more.

First-in-class

patented and proprietary technology, currently undergoing multiple clinical trials.

Brock S.

Brock S. — Melanoma, Stage 4

Rapidly growing metastasis in lungs. Multiple failed immunotherapies. Treated December 2022. Confirmed no evidence of disease (NED) November 2023.

Kevin C.

Kevin C. — Melanoma, Stage 2C

Large tumor burden on lip. Underwent multiple surgeries. Treated April 2023. Confirmed NED fall 2023.

Babette L.

Babette L. — Ovarian, Stage 4

Significant tumor burden across groin, pelvis, chest, and thorax. Treated December 2022. Metastases resolved, leaving only scarring tissue.

04 — Venue & Logistics

Cancún, México.
August 7–9.

We picked Cancún because the science deserves a setting that matches it. Oceanfront. Easy to get to. Hard to want to leave.

Property

JW Marriott Cancún Resort & Spa
Cancún Hotel Zone, Quintana Roo, México

Getting There

Direct flights available from most major U.S. cities.
~20–30 min from Cancún International Airport (CUN).

All travel arranged by our team.

Weather

Warm and sunny. Expect 28–32°C / 82–90°F.
Pack light.

Our team handles all logistics once you confirm. Reach out with any questions at: mwrona@immunocine.com.

JW Marriott Cancún Resort & Spa
Aerial view of the Cancún hotel zone

05 — Why You're Here

You were invited for a reason.

70%

of patients are surviving today — the majority Stage 4.

74%

stable or improving across all cancer types treated.

15

patients confirmed No Evidence of Disease (NED) — verified by each patient's own independent oncologist.

Data from 64 patients treated across 9 cancer types including breast, prostate, melanoma, colorectal, and ovarian. Average follow-up: 10.2 months.

Dr. Matthew Halpert presenting at the Immunocine Summit

06 — The Team

Meet the people behind the science.

The sessions are led by Immunocine's own medical team — the same doctors who treat patients every day and built the protocol from the ground up.

Matthew Halpert, PhD

Matthew Halpert, PhD

Founder and CEO
Immunocine Cancer Center

Jay Hartenbach

Jay Hartenbach

President & CEO
Diakonos

Stephen Noga, MD, PhD

Stephen Noga, MD, PhD

Patient Oncology Advisor
Immunocine Cancer Center

Daniel Rubin, ND, FABNO

Daniel Rubin, ND, FABNO

Director of Integrative Oncology
Immunocine Cancer Center

Rafael Gonzalez, PhD

Rafael Gonzalez, PhD

Scientific Advisor
Immunocine Cancer Center

Janet Maendel, DO

Janet Maendel, DO

Metabolic Oncology Consultant
Immunocine Cancer Center

07 — Common Questions

Anything you're wondering about.

Flights, hotel, and airport ground transfers are fully covered. There's no registration fee and no catch.

Invitations were extended personally to physicians whose work and patient profiles align with what we're doing at Immunocine. If you received this invitation, you belong here.

This is an intentionally small group. Seats are very limited to keep the conversation meaningful. We expect to have roughly 20 invitees alongside 10 Immunocine team members.

No preparation required. Come curious. We'll handle the rest.

Please reach out to us directly at mwrona@immunocine.com to discuss. Invitations are personal but we're happy to discuss.

Smart casual for sessions. Casual for everything else. You're in Cancún — dress accordingly.

Email us at mwrona@immunocine.com. We'll get back to you within 24 hours.